Stanford and Cal have experienced a slew of ghastly weekends since their seasons of concurrent relevance more than a decade ...
Spyre Therapeutics Inc (NASDAQ:SYRE) shares fell 2.9% in after-hours trading Monday following the company's announcement of an underwritten public offering of its common stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results